Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
 9 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Cash flows from operating activities:    
Net loss $ (3,378,825) $ (5,046,674)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation 3,561 835
Stock-based compensation 1,282,052 1,578,663
Noncash interest expense on notes payable 0 22,118
Issuance of restricted stock for services 0 162,000
Decrease to fair value of derivative (1,837,527) (426,832)
(Increase) decrease in:    
Prepaid expenses (2,382) (43,508)
Increase (decrease) in:    
Accounts payable (81,722) (168,762)
Accrued expenses and other liabilities (73,002) (135,303)
Accrued interest 0 (331,000)
Net cash used in operating activities (4,087,845) (4,388,463)
Cash flows from investing activities:    
Purchases of property and equipment (15,494) (4,293)
Net cash used in investing activities (15,494) (4,293)
Cash flows from financing activities:    
Proceeds from exercise of warrants 63,388 537,659
Proceeds from subscribed but unissued common stock and warrants 4,535,000 0
Proceeds from issuance of common stock and warrants 0 5,987,122
Payments on note payable 0 (1,000,000)
Net cash provided by financing activities 4,598,388 5,524,781
Net increase in cash 495,049 1,132,025
Cash, beginning of year 5,994,052 5,036,476
Cash, end of period 6,489,101 6,168,501
Non-cash financing activities:    
Warrant derivative liability 2,397,454 2,996,110
Financing costs on issuance of common stock and warrants 80,000 0
Exercise of stock options - cashless 117 107
Restricted stock - vested 233 0
Cash paid for    
Interest on note $ 0 $ 361,268